Canton Strategic Holdings (CNTN) Change in Accured Expenses (2021 - 2026)

Canton Strategic Holdings (CNTN) reported Change in Accured Expenses of -$1.5 million for Q1 2026, down 22752.21% on a YoY basis from N/an in Q1 2025, and down 196.73% quarter-over-quarter from $1.5 million in Q4 2025.

Canton Strategic Holdings (CNTN) Change in Accured Expenses (2021 - 2026) Analysis & Trends

Canton Strategic Holdings has reported Change in Accured Expenses for 6 years, with the latest figure at -$1.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 22752.21% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$378695.0 (down 147.91% YoY), and the FY2025 full-year result was $1.1 million, up 156.55% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$1.5 million, down from $1.5 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $1.5 million in Q4 2025, with the low at -$1.5 million in Q1 2026.
  • Historically, Change in Accured Expenses has averaged $36530.7 across 5 years, with a median of -$6376.0 in 2025.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 6658.29% — and 2026, when it tumbled 22752.21%.
  • Canton Strategic Holdings' Change in Accured Expenses stood at $10597.0 in 2022, then soared by 6658.29% to $716176.0 in 2023, then plunged by 106.25% to -$44774.0 in 2024, then surged by 3464.2% to $1.5 million in 2025, then plunged by 196.73% to -$1.5 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$1.5 million (Q1 2026), $1.5 million (Q4 2025), and -$368137.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn - -1.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.46 Mn
Mar 31, 2026 -1.46 Mn
Dec 31, 2025 1.51 Mn
Dec 31, 2025 1.51 Mn
Sep 30, 2025 -368,137.00
Sep 30, 2025 -368,137.00
Jun 30, 2025 -59,787.00
Jun 30, 2025 -59,787.00
Mar 31, 2025 -6,376.00
Mar 31, 2025 -6,376.00
Dec 31, 2024 -44,774.00
Dec 31, 2024 -44,774.00
Sep 30, 2024 789,628.00
Sep 30, 2024 789,628.00
Jun 30, 2024 51,935.00
Jun 30, 2024 51,935.00
Mar 31, 2024 -378,942.00
Mar 31, 2024 -378,942.00
Dec 31, 2023 716,176.00
Dec 31, 2023 716,176.00